{
  "ticker": "LLY",
  "target_date": "2025-05-20",
  "actual_date": "2025-05-20",
  "collected_at": "2025-12-08T11:47:15.279158",
  "price": {
    "open": 753.24,
    "high": 760.71,
    "low": 740.28,
    "close": 744.27978515625,
    "volume": 3873500,
    "change_1d_pct": -1.07,
    "change_7d_pct": 1.9,
    "change_30d_pct": 3.43
  },
  "technicals": {
    "rsi_14": 27.97,
    "sma_20": 791.81,
    "sma_50": 793.58,
    "macd": -19.221,
    "macd_signal": -15.06,
    "macd_histogram": -4.161,
    "bb_upper": 908.89,
    "bb_lower": 674.72,
    "price_vs_sma20_pct": -6.0,
    "price_vs_sma50_pct": -6.21,
    "volume_ratio": 0.77
  },
  "fundamentals": {
    "market_cap": 892395782144,
    "pe_ratio": 48.77364,
    "forward_pe": 43.930714,
    "price_to_book": 37.480045,
    "price_to_sales": 15.018492,
    "profit_margin": 30.99,
    "operating_margin": 48.29,
    "roe": 96.47,
    "roa": 17.6,
    "revenue_growth": 53.9,
    "earnings_growth": 480.4,
    "debt_to_equity": 178.516,
    "current_ratio": 1.546,
    "quick_ratio": 0.724,
    "dividend_yield": 59.0,
    "fifty_two_week_high": 1111.99,
    "fifty_two_week_low": 623.78,
    "fifty_day_avg": 911.5326,
    "two_hundred_day_avg": 811.9354,
    "analyst_target": 1056.7045,
    "analyst_recommendation": "buy",
    "num_analysts": 27,
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - General",
    "pct_from_52w_high": -10.48,
    "pct_from_52w_low": 59.59
  },
  "macro": {
    "spy": {
      "price": 589.47,
      "change_1d_pct": -0.34,
      "change_7d_pct": 1.69
    },
    "vix": {
      "level": 18.09,
      "signal": "NORMAL"
    },
    "treasury_10y": {
      "yield_pct": 4.48
    },
    "dollar_index": {
      "level": 100.12
    },
    "gold": {
      "price": 3280.3
    },
    "regime": "BULL_NORMAL"
  },
  "news": [
    {
      "headline": "Novo Nordisk Places Bet on CEO Shake-Up to Reclaim Edge in Weight Loss Drug Race",
      "source": "Yahoo",
      "datetime": 1747763372,
      "summary": "As its obesity medication Wegovy loses a sizable portion of the market to Eli Lilly and Company (NYSE:LLY)\u2019s competing medicine, Zepbound, the Danish pharmaceutical behemoth Novo Nordisk A/S (NYSE:NVO) abruptly announced the resignation of veteran CEO Lars Fruergaard J\u00f8rgensenm last week. The stock ",
      "url": "https://finnhub.io/api/news?id=6a826ca022fda9728a3597b7b8e51d819a5f0268a99c9ce8c9ec7af85843b51d"
    },
    {
      "headline": "Janus Henderson Forty Fund Q1 2025 Commentary",
      "source": "SeekingAlpha",
      "datetime": 1747757700,
      "summary": "Janus Henderson Forty Fund returned -8.74% and the Russell 1000\u00c2\u00ae Growth Index returned -9.97%. Read more here.",
      "url": "https://finnhub.io/api/news?id=4e3385abeb5a134ea512c831a93c9a651f051f8304f316c22b169cee35a9bf77"
    },
    {
      "headline": "XLG: Build Your Portfolio With The Best 50 Stocks",
      "source": "SeekingAlpha",
      "datetime": 1747745921,
      "summary": "Discover why the Invesco S&P 500 Top 50 ETF (XLG) is a strong buy with sector-leading stocks, outperformance, a low 0.2% expense ratio, and long-term growth.",
      "url": "https://finnhub.io/api/news?id=7d8354c7dc5619af5c3a098eb9fd382fd0c54cc9906dc2569eda769aa04dae77"
    },
    {
      "headline": "Novo Nordisk Woes Just Hit Denmark\u2019s Economy.  The Stock Is Rising.",
      "source": "MarketWatch",
      "datetime": 1747738800,
      "summary": "Novo Nordisk Woes Just Hit Denmark\u2019s Economy.  The Stock Is Rising.",
      "url": "https://finnhub.io/api/news?id=8a4124f532f26ad3af5c7dc2750fc51c4bb535ff9f220fa891588691fd18834b"
    },
    {
      "headline": "Janus Henderson Global Life Sciences Diversified ADR Managed Account Q1 2025 Commentary",
      "source": "SeekingAlpha",
      "datetime": 1747732200,
      "summary": "The Portfolio returned 1.36% (gross) and the MSCI World Health Care Index SM returned 5.29%.",
      "url": "https://finnhub.io/api/news?id=62b609fa1d5756badcdc2024a29cd0511dca54f3d6b9f9baa7ca9b6096bc8b15"
    }
  ],
  "news_count": 5,
  "sec_filings": [
    {
      "form": "4",
      "date": "2025-05-20",
      "description": "xslF345X05/wk-form4_1747772733.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000154/xslF345X05/wk-form4_1747772733.xml"
    },
    {
      "form": "4",
      "date": "2025-05-20",
      "description": "xslF345X05/wk-form4_1747772668.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000152/xslF345X05/wk-form4_1747772668.xml"
    },
    {
      "form": "4",
      "date": "2025-05-20",
      "description": "xslF345X05/wk-form4_1747772589.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000150/xslF345X05/wk-form4_1747772589.xml"
    },
    {
      "form": "4",
      "date": "2025-05-20",
      "description": "xslF345X05/wk-form4_1747772518.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000148/xslF345X05/wk-form4_1747772518.xml"
    },
    {
      "form": "4",
      "date": "2025-05-20",
      "description": "xslF345X05/wk-form4_1747772448.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000146/xslF345X05/wk-form4_1747772448.xml"
    }
  ],
  "sec_filings_count": 5,
  "data_quality": {
    "has_price": true,
    "has_technicals": true,
    "has_fundamentals": true,
    "has_macro": true,
    "has_news": true,
    "has_sec_filings": true
  }
}